LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.40 | 84.90 | 1139 | 1454 | 0.7830 | 0.8841 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.40 | 84.90 | 1239 | 1454 | 0.8517 | 0.9232 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.10 | 84.90 | 1 | 1616 | 0.0006 | -0.6483 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.10 | 84.90 | 1201 | 1616 | 0.7431 | 0.8651 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.10 | 84.90 | 12 | 1616 | 0.0074 | -0.3689 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.10 | 84.90 | 978 | 1616 | 0.6051 | 0.7771 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.10 | 84.90 | 1187 | 1616 | 0.7344 | 0.8599 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.10 | 84.90 | 1270 | 1616 | 0.7858 | 0.8897 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.81 | 84.90 | 2 | 1769 | 0.0011 | -0.5749 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.81 | 84.90 | 1252 | 1769 | 0.7075 | 0.8482 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.81 | 84.90 | 9 | 1769 | 0.0051 | -0.4008 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.81 | 84.90 | 988 | 1769 | 0.5584 | 0.7509 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.81 | 84.90 | 1253 | 1769 | 0.7081 | 0.8485 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.81 | 84.90 | 1332 | 1769 | 0.7528 | 0.8745 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 26.51 | 84.90 | 12 | 1923 | 0.0062 | -0.3525 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 26.51 | 84.90 | 1328 | 1923 | 0.6905 | 0.8421 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 26.51 | 84.90 | 15 | 1923 | 0.0078 | -0.3196 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 26.51 | 84.90 | 1030 | 1923 | 0.5356 | 0.7410 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 26.51 | 84.90 | 1329 | 1923 | 0.6911 | 0.8424 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 26.51 | 84.90 | 1399 | 1923 | 0.7275 | 0.8635 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 28.21 | 84.90 | 6 | 2091 | 0.0029 | -0.4363 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 28.21 | 84.90 | 1358 | 2091 | 0.6493 | 0.8216 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 28.21 | 84.90 | 22 | 2091 | 0.0105 | -0.2533 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 28.21 | 84.90 | 1082 | 2091 | 0.5173 | 0.7343 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 28.21 | 84.90 | 1367 | 2091 | 0.6536 | 0.8242 | MN20160318_Q02 | K06 |